Novidades

Novidades e Eventos

China Food and Drug Administration Approves ORTHO VISION® Platform for Transfusion Medicine Labs

Oct 25, 2017

Immunohematology System from Ortho Clinical Diagnostics Now Commercially Available in China

Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF Diagnostics

Oct 11, 2017

EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body Now Available on Ortho’s VITROS® 4600 and VITROS® 5600

Ortho Clinical Diagnostics to Present Data on Automation in Immunohematology and Demonstrate Its Entire Transfusion Medicine Portfolio at the 2017 AABB Annual Meeting

Oct 2, 2017

Industry Workshop to Address Clinical Outcomes of Titration Studies Using ID-MTS™ Gel Test Method

FDA Licenses Blood Grouping Reagents for Extended Phenotype Testing: ORTHO™ Sera Featured in CLP

Sep 26, 2017

“Ortho Sera helps increase confidence in the lab and allow staff to focus on improving lab efficiency,” says Robert Yates, chief operating officer at Ortho.

FDA Approves Two Ortho Clinical Diagnostics Specialty Hepatitis B Assays

Sep 14, 2017

Approval exemplifies Ortho’s commitment to expand menu while streamlining lab operations

Ortho Clinical Diagnostics Announces Global Agreement to Make B·R·A·H·M·S PCT Assay Available to Ortho Customers

Jul 31, 2017

Assay plays key role in aiding clinicians in the assessment and treatment of sepsis and septic shock

Ortho Clinical Diagnostics Awarded Distinguished #1 Ranking for Service Performance for 2nd Year in a Row

Jul 27, 2017

In Vitro Diagnostics Industry Rankings Published by ServiceTrak™

 

Ortho Clinical Diagnostics to Present 10 Scientific Posters, Seven Products at AACC

Jul 26, 2017

Activities at the annual meeting of American Association for Clinical Chemistry will demonstrate Ortho’s focus on immunodiagnostics and acute kidney injury

Ortho Clinical Diagnostics Receives CE Mark for Ortho’s VITROS® Insulin Reagent & Calibrators

Jul 21, 2017

Assay will be commercially available in third quarter in countries accepting CE Mark

Ortho Clinical Diagnostics Receives FDA 510(k) Clearance for Ortho’s VITROS® Insulin Reagent & Calibrators

Jun 26, 2017

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that Ortho’s VITROS®

Ortho Clinical Diagnostics to Present Data on Early Detection Of Acute Kidney Injury Risk, Immunoassay Development at EUROMEDLAB Athens 2017

Jun 12, 2017

Sponsored educational sessions and product demonstrations at IFCC’s EUROMEDLAB Athens conference for lab professionals

Ortho Clinical Diagnostics VITROS® NephroCheck® Test for Prediction of Acute Kidney Injury Cleared, Available in Europe

Jun 6, 2017

AKI, the sudden loss of kidney function, can develop without warning and potentially lead to kidney failure and death. Known as a silent killer, AKI is as common and twice as deadly as a heart attack.
Learn more  

Ortho Chairman and CEO Martin Madaus on Innovation Within the In Vitro Diagnostics Industry: It’s a Decathlon

May 16, 2017

t’s not a sprint, it’s a decathlon. Ortho Chairman and CEO Martin Madaus on innovation within the in vitro diagnostics industry.

Edison Awards Recognize Ortho Clinical Diagnostics for Outstanding Product Innovation

Apr 21, 2017

Ortho Clinical Diagnostics has been awarded an Edison Award™ for Global Product Innovation, for its ORTHO VISION® Platform.

Ortho Clinical Diagnostics Featured in Rochester Business Journal

Apr 7, 2017

Ortho was featured in a recent edition of the Rochester Business Journal regarding our commitment to global R&D and our customers.

Ortho Clinical Diagnostics to Present Data on Early Detection Of Acute Kidney Injury, Total Lab Automation and Transfusion Medicine at MEDLAB Asia Pacific 2017

Apr 4, 2017

Ortho will sponsor five author presentations and four poster presentations at MEDLAB Asia Pacific Exhibition & Congress 2017

Ortho Clinical Diagnostics Announces Expansion Of Global Agreement With Astute Medical for NephroCheck Test

Mar 13, 2017

Agreement gives Ortho expanded distribution rights in Europe for the NephroCheck Test on the ASTUTE140 platform. 

Ortho Clinical Diagnostics Awarded Top Honor for Global Excellence in Customer Service

Feb 27, 2017

Ortho Care™ Support Program Recognized As Best-in-Class Service and Support for Hospitals, Hospital Networks, Blood Banks & Labs

Ortho Clinical Diagnostics Submits VITROS® Immunodiagnostic Products HIV Combo Assay to FDA for Review; Applies to Expand Use of Specialty Hepatitis B Assays

Feb 23, 2017

Latest submissions exemplify Ortho’s commitment to expand menu while streamlining lab operations 

Ortho Clinical Diagnostics Recognized with Two Global Business Excellence Awards

Feb 2, 2017

ORTHO VISION® Analyzer Wins International Awards for ‘Outstanding Innovation’ and ‘Outstanding Product/Service’

 

Ortho Clinical Diagnostics Celebrates 1,000 Installations of the ORTHO VISION® Platform Worldwide

Jan 24, 2017

This accomplishment is recognition of the ORTHO VISION® platform’s value to customers, and represents faster growth than Ortho’s previous products in this space.

GenomeWeb’s 360Dx Highlights CE Mark Approval of ORTHO CONNECT™ V2.0 Middleware Solution

Jan 12, 2017

ORTHO CONNECT is a comprehensive, integrated, customizable intermediary software that streamlines laboratory operations, allowing lab professionals to manage multiple instruments from a single console

Medical Laboratory Observer Publishes Article by Ortho’s Michael S. Iskra

Dec 22, 2016

Michael S. Iskra details steps laboratories can take to be an integral force in driving hospitals’ strategic priorities.

Ortho’s Alex Socarrás is Featured in an Exclusive Radio Interview with El Microscopio

Dec 19, 2016

Alex Socarrás discusses our strategy, new products, our customer focus and trends in the clinical laboratory space in Latin America and worldwide.

GenomeWeb’s 360Dx Feature Story Covers Ortho’s Momentum, Growth

Dec 14, 2016

Ortho’s growth and momentum were covered in the first edition of the new diagnostics-focused publication, 360Dx.

CAP Today Highlights FDA Clearance of ORTHO VISION® Max Analyzer

Nov 4, 2016

Read the recent CAP Today article on the FDA Clearance of the ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine Labs.

Ortho’s VITROS® Automation Solutions Featured in FDA News

Oct 30, 2016

Ortho's momentum is growing, as we launched two new products to enable better, faster diagnostics in October, 2016. Read about our VITROS® Automation Solutions in FDA News.

FDA Clears VITROS® Automation Solutions from Ortho Clinical Diagnostics

Oct 28, 2016

Open, flexible and scalable platform empowers laboratory clinicians to take total facility control

Ortho Colleagues Blog about Workshops on Mass Transfusion Protocol and Reducing the Risk of Alloimmunization at 2016 AABB Annual Meeting

Oct 27, 2016

Two Ortho colleagues recently guest-blogged for AABB about workshops on mass transfusion protocol in the wake of tragic events, and reducing the risk of alloimmunization during blood transfusion.

FDA Clears ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine Labs

Oct 22, 2016

New Immunohematology System from Ortho Clinical Diagnostics Expands ORTHO VISION® Platform; Now Commercially Available in the United States

Ortho Clinical Diagnostics to Present Data on Automation in Immunohematology, Three Products at 2016 AABB Annual Meeting

Oct 19, 2016

Customer event will feature analysis of mass transfusion protocol implementation in the wake of Orlando attack

Ortho Exec Featured in Industry Publication

Sep 26, 2016

Heidi Casaletto, Ortho’s VP of Transfusion Medicine, was featured in the recent article, "Building a Safer Blood Supply,” in CLP Magazine

Marion General Hospital Addresses Growing Pressures with Lab Data Management from Ortho Clinical Diagnostics

Sep 6, 2016

A Recent Video on Customer Experience of Ortho Clinical Diagnostics’ Lab Data Management Solution at Marion General Hospital

Holistic Support Program Offers Guidance for Labs, Blood Banks

Aug 15, 2016

"This type of support is now more critical than ever," said Ortho’s Alex Socarrás in a recent article in CLP Magazine.

Ortho Clinical Diagnostics Featured in Clinical Lab Products

Aug 9, 2016

Ortho Clinical Diagnostics was featured in a recent article in Clinical Lab Products magazine

Ortho Clinical Diagnostics Announces Ortho Care

Aug 2, 2016

Best-in-Class Service and Support Program for Hospitals, Hospital Networks, Blood Banks and Labs

Ortho Clinical Diagnostics Highlighted in Medical Lab Observer

Aug 1, 2016

Ortho will present seven scientific posters on its assays and display six products at its booth at the 2016 AACC annual meeting.

Ortho Clinical Diagnostics to Present Seven Scientific Posters, Six Products at AACC

Jul 25, 2016

Ortho will present seven scientific posters on its assays and display six products at its booth at the 2016 AACC annual meeting.

Ortho Clinical Diagnostics Receives Coveted #1 Ranking for Service Performance

Jul 19, 2016

Ortho Clinical Diagnostics announced that it was ranked higher than any other company for overall service performance by an OEM in the in vitro diagnostics industry.

Karen Davis-Fleischer, vice president Business Fields at Ortho, was featured in a recent article in Clinical Lab Products

Jul 13, 2016

Karen Davis-Fleischer, VP Business Fields at Ortho, was featured in a recent article in Clinical Lab Products

ORTHO VISION® Analyzer Named Innovation Celebration Award Winner at Premier’s Annual Meeting

Jun 23, 2016

Ortho Clinical Diagnostics today announced that its ORTHO VISION® Analyzer has been recognized with a 2016 Innovation Award by members of Premier, Inc.

Ortho Clinical Diagnostics Receives CE Mark Approval For VITROS® Immunodiagnostic HIV Combo Test*

Jun 21, 2016

New Test Expands Infectious Disease Assay Portfolio; Will Become Commercially Available in Europe and Other Countries that Accept CE Mark This Month

Beckman Coulter and Ortho Clinical Diagnostics Announce Strategic Relationship to Deliver Infectious Disease Testing Menu to Very High-Volume Labs

Jun 8, 2016

Beckman Coulter Diagnostics to Place Ortho’s VITROS® 3600 Systems in Very High-Volume Labs

Ortho Clinical Diagnostics and Beckman Coulter Strategic Relationship Highlighted in CAP TODAY

Jun 8, 2016

Beckman Coulter Diagnostics to Place Ortho’s VITROS® 3600 Systems in Very High-Volume Labs

Ortho Clinical Diagnostics Presents Scientific Poster on the Capabilities of fourth-generation HIV Assay at the 32nd Clinical Virology Symposium

May 23, 2016

Ortho Clinical Diagnostics has presented the initial performance capabilities of its fourth-generation HIV Test in development.

Ortho Clinical Diagnostics Announces Availability of ORTHO™ Sera Extended Phenotype Testing on ORTHO VISION® Analyzer for BioVue® Cassettes

Apr 28, 2016

Ortho Clinical Diagnostics today announced that ORTHO™ Sera, a fully automated solution for extended antigen phenotyping, is now available on the ORTHO VISION® Analyzer.

Ortho Chairman and CEO Martin Madaus Featured in FierceMedicalDevices

Apr 25, 2016

Ortho’s Chairman and CEO speaks about the Company’s progress as an independent company in this Q&A interview with FierceMedicalDevices

Ortho’s Jennifer Paine named to Becker’s Women to Watch in Med Tech list

May 8, 2017

Jennifer Paine, Ortho’s EVP of Worldwide Quality, Regulatory and Compliance, has been named to Becker’s Hospital Review’s prestigious “Women to Watch in Med Tech” list.

Ortho Clinical Diagnostics Presents Scientific Poster on the Performance of a Fourth-Generation HIV Test at the 2016 HIV Diagnostics Conference

Mar 28, 2016

Ortho Clinical Diagnostics presented a scientific poster at the 2016 HIV Diagnostics Conference on the performance of its Fourth-Generation HIV Test in development.

Ortho Clinical Diagnostics Releases New Infographic – “Changing Dynamics in the Hospital Lab: Generalists and Specialists”

Mar 28, 2016

Our new infographic explores how generalists and specialists differ and the unique ways in which they collaborate in the blood banking field.

Ortho's Mary Pat Cottengim Named One of Digital Rochester's '2016 Tech Woman of Year' Nominees

Mar 24, 2016

Digital Rochester has announced the 14 nominees for its 2016 Technology Woman of the Year award, including Mary Pat Cottengim, human factors & usability lead for Ortho Clinical Diagnostics.

Ortho Clinical Diagnostics Highlighted in the Waterloo-Cedar Falls Courier

Feb 16, 2016

Waterloo's Covenant Medical Center is the first medical facility in Iowa to install the ORTHO VISION™ Analyzer.

Ortho Chairman and CEO Martin Madaus Featured in Medical Laboratory Observer

Dec 1, 2015

Ortho's Chairman and CEO speaks about the Company's pioneering spirit and how it is driving forward as a global partner for clinical laboratories and transfusion medicine.

Terre Haute Regional Hospital Becomes First to Install the ORTHO VISION™ Analyzer

Nov 12, 2015

Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION™ Analyzer.

Ortho Clinical Diagnostics Featured in The Kansan

Nov 6, 2015

Newton Medical Center is the first hospital in the U.S. to order new transfusion medicine analyzer.

Ortho Clinical Diagnostics’ Executive Leader, Jennifer Paine, Recognized by The Regulatory Affairs Professionals Society as a 2015 Top 10 Honoree

Oct 21, 2015

Jennifer Paine, executive vice president of worldwide quality, Regulatory & Compliance, has been recognized by the Regulatory Affairs Professionals Society as a 2015 Top 10 Honoree.

Ortho Clinical Diagnostics Receives CE Mark Clearance for ORTHO VISION™ Max Analyzer for High-Volume Transfusion Medicine Labs

Oct 14, 2015

Ortho Clinical Diagnostics' ORTHO VISION™ Max, a fully automated blood analyzer for high-volume transfusion medicine laboratories, receives CE Mark clearance.

Ortho Clinical Diagnostics Featured in Clinical Laboratory International

Oct 1, 2015

Ortho Clinical Diagnostics researchers present data on pipeline of assays.

Ortho Clinical Diagnostics Receives 510(k) Clearance for ORTHO VISION™ Analyzer, Making it Commercially Available in the United States

Aug 18, 2015

Ortho Clinical Diagnostics receives 510(k) clearance for ORTHO VISIONTM Analyzer, making it commercially available in the United States.

Ortho Clinical Diagnostics Presents Data on Five Assays in Development at American Association for Clinical Chemistry Annual Meeting

Jul 29, 2015

Ortho Clinical Diagnostics presents data on five assays in development at the American Association for Clinical Chemistry's annual meeting.

Ortho Clinical Diagnostics Receives FDA 510(k) Clearance for VITROS® Chemistry Products HbA1c Reagent Kit, an Enhanced Diabetes Testing Assay

Jun 18, 2015

Ortho Clinical Diagnostics receives FDA 510(k) clearance for VITROS® Chemistry Products HbA1c Reagent Kit, an enhanced diabetes testing assay.

Ortho Clinical Diagnostics and Quotient Announce Agreement to Commercialize Innovative Transfusion Medicine Diagnostic Platform, MosaiQ™

Jan 29, 2015

Ortho Clinical Diagnostics and Quotient announce an agreement to commercialize innovative transfusion medicine diagnostic platform MosaiQTM

Ortho Clinical Diagnostics Sponsors AACC Webinar Nov. 19: 'Clinical Application of Recently Approved Biomarkers of Acute Kidney Injury'

Nov 11, 2014

Ortho Clinical Diagnostics sponsors the American Association for Clinical Chemistry webinar: Clinical Application of Recently Approved Biomarkers of Acute Kidney Injury.

Ortho Clinical Diagnostics Receives CE Mark for ORTHO VISION™ Analyzer to take Full Automation Transfusion Medicine Testing to Next Level

Oct 28, 2014

Ortho Clinical Diagnostics receives CE Mark for ORTHO VISION™ Analyzer to take full automation transfusion medicine testing to the next level.

Ortho Clinical Diagnostics Receives CE Mark for VITROS® Chemistry Products HbA1c Reagent Kit, an Enhanced Diabetes Testing Assay

Oct 17, 2014

Ortho Clinical Diagnostics receives CE Mark for VITROS® Chemistry Products HbA1c Reagent Kit, an enhanced diabetes testing assay.

Ortho Clinical Diagnostics Signs Agreement with Astute Medical, Inc. to Commercialize and Develop Innovative Acute Kidney Injury Tests

Jul 28, 2014

Ortho Clinical Diagnostics signs agreement with Astute Medical, Inc. to commercialize and develop innovative acute kidney injury tests.

Ortho Clinical Diagnostics, Inc. Announces Executive Leadership Additions as it Becomes an Independent, Stand Alone Company

Jul 8, 2014

Ortho Clinical Diagnostics announces executive leadership appointments as it becomes an independent, stand alone company.

Ortho Clinical Diagnostics Receives CE Mark Approval for ORTHO CONNECT™ V2.0 Middleware Solution

Jan 11, 2017

ORTHO CONNECT™ V2.0 is now commercially available in Europe and other countries accepting CE Mark

Martin Madaus Discusses Ortho's Growth Story on CNBC’s Squawk Box

Aug 10, 2017

How to Manage a Large, Complex Corporate Carve-Out Well: Ortho CEO Dr. Martin Madaus on ​CNBC's Squawk Box

© Ortho Clinical Diagnostics 2018. Este site é publicado pela Ortho Clinical Diagnostics, que é a única responsável por seu conteúdo. A disponibilidade do produto está sujeita ao cumprimento das exigências regulamentares em cada mercado. Este site foi escrito em português do Brasil e é apenas para os profissionais da saúde. Data da última modificação: 24-08-2017 04:17

${loading}